arrow
A

Alberto C. S. Costa

University System of Ohio
H指数:29
被引数:3,056

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Baseline Neuropsychological Characteristics of Adolescents and Young Adults with Down Syndrome Who Participated in Two Clinical Trials of the Drug Memantine

参与两种美金刚药物临床试验的唐氏综合征青少年和年轻成人的基线神经心理学特征

2025-10-290
OAAI
Imagine, Discover, Inspire: Proceedings of the 4th International Conference of the Trisomy 21 Research Society

想象,发现,启发: 21三体研究学会第四届国际会议论文集

2025-01-050
OAAI
COVID-19 Vaccination of Individuals with Down Syndrome-Data from the Trisomy 21 Research Society Survey on Safety, Efficacy, and Factors Associated with the Decision to Be Vaccinated

唐氏综合症患者的新型冠状病毒肺炎疫苗接种-来自21三体研究协会关于安全性,有效性和与决定接种疫苗相关的因素的调查数据

2022-03-297
OAAI
Safety, efficacy, and tolerability of memantine for cognitive and adaptive outcome measures in adolescents and young adults with Down syndrome: a randomised, double-blind, placebo-controlled phase 2 trial
2022-01-0112
PRE
COVID-19 in Children with Down Syndrome: Data from the Trisomy 21 Research Society Survey
2021-10-3129
OAAI
Cross-Sectional Exploration of Plasma Biomarkers of Alzheimer's Disease in Down Syndrome: Early Data from the Longitudinal Investigation for Enhancing Down Syndrome Research (LIFE-DSR) Study
2021-04-2815
OAAI
Medical vulnerability of individuals with Down syndrome to severe COVID-19-data from the Trisomy 21 Research Society and the UK ISARIC4C survey
2021-03-0176
OAAI
Soluble prion protein and its N-terminal fragment prevent impairment of synaptic plasticity by Aβ oligomers: Implications for novel therapeutic strategy in Alzheimer's disease

可溶性朊蛋白及其N末端片段可防止a β 寡聚体对突触可塑性的损害: 对阿尔茨海默氏病新型治疗策略的影响

2016-07-0143
OAAI